Company / EPS (Diluted)
Mirum Pharmaceuticals, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.00
FY2025
5-year range
-$4.09 / -$2.77
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
#164 of 204
Health Care
What the data says
Mirum Pharmaceuticals, Inc.'s eps (diluted) of $-4.00 is lower than 80% of companies in the Health Care sector (FY2025). Declined from $-2.77 to $-4.00 over the past 2 years.
Based on SEC 10-K filings.
-4.00 in FY2025.
Declined from $-2.77 to $-4.00 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 204This company -$4.00 Sector average -$0.98
▼
-308.3% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 0.5% year-over-year.
- Ranks #164 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.00 | +0.5% |
| FY2024 | -$4.02 | -45.1% |
| FY2023 | -$2.77 | +0.0% |
| FY2022 | -$2.77 | +32.3% |
| FY2021 | -$4.09 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026